Mild Recessive Bullous Congenital Ichthyosiform Erythroderma due to a Previously Unidentified Homozygous Keratin 10 Nonsense Mutation  by Tsubota, Akiko et al.
Mild Recessive Bullous Congenital Ichthyosiform
Erythroderma due to a Previously Unidentified
Homozygous Keratin 10 Nonsense Mutation
Akiko Tsubota1, Masashi Akiyama1, Jean Kanitakis2, Kaori Sakai1, Toshifumi Nomura1, Alain Claudy2 and
Hiroshi Shimizu1
We have identified a previously unreported homozygous nonsense mutation p.Cys427X in the keratin 10 (K10)
gene (KRT10) in a Turkish girl with recessive bullous congenital ichthyosiform erythroderma (BCIE) showing
superficial blistering. p.Cys427X is located upstream of the previously reported homozygous truncation
mutation within the same exon 6 causing mRNA decay. Immunohistochemical examination showed a complete
absence of K10 protein in the patient’s epidermis. The findings of this study suggest that K10 knockout patients
show unique clinicopathological features of clinically mild BCIE with blisters occurring within the granular
layer. In addition, the unaffected, heterozygous carriers of the mutation indicate that the K10 peptide from one
normal allele alone is sufficient for keratin network formation.
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INTRODUCTION
Most families affected by inherited keratin diseases present
autosomal-dominant transmission, although a small number
of keratin knockout families showing recessive inheritance
have been reported. In recessive epidermolysis bullosa
simplex, keratin 14 (K14) knockout families presented a very
severe phenotype (Chan et al., 1994; Jonkman et al., 1996).
We report here a K10 knockout Turkish girl harboring a
previously unidentified homozygous truncation mutation of
the K10 gene (KRT10), whose phenotype was mild bullous
congenital ichthyosiform erythroderma (BCIE) with granular
degeneration and blister formation restricted to the granular
layer of the epidermis.
RESULTS
Unique clinical features of mild BCIE
The proband, a 3-year-old Turkish girl, was the fourth child
born to unaffected, healthy parents who were first cousins
(their fathers were brothers). The patient had two elder sisters
and one elder brother, who were unaffected. There was no
known family history of skin diseases. The patient was born
with widespread, diffuse skin blistering and erosive lesions
(Figure 1a and b). At the age of 3 years, she was still
developing skin erosions at the sites of trauma (mainly on the
face and trunk) and had brownish, hyperkeratotic lesions over
her chest, arms, back, and knees (Figure 1c and d). She also
developed scaly, keratotic lesions on her scalp. Palmoplantar
areas were not affected. Nails, hair, and teeth were normal.
Physical and mental growth was normal.
Granular degeneration and keratin clumps are restricted to the
granular layer
A skin biopsy obtained, soon after birth, from a bullous lesion
of the trunk revealed orthohyperkeratosis and granular
degeneration with acantholysis restricted to the granular
layer (Figure 2a). By electron microscopy, the keratin filament
network was disrupted only in the uppermost keratinocytes
of the spinous layer and the granular layer. Perinuclear shells
of clumped keratin filaments, as often observed in autosomal-
dominant BCIE patients, were absent. Irregularly shaped
keratin clumps and cytolysis were seen in the uppermost
spinous and granular layers (Figure 2b).
A homozygous truncation mutation in KRT10 is identified in the
patient
We therefore sequenced KRT10 and found a previously
unidentified homozygous two base-pair exchange (CC to AA)
at base pair position 1281_1282 in exon 6 of KRT10
(c.1281_1282CC4AA) in the patient (Figure 3a). This
exchange resulted in a substitution of a cysteine residue
(TGC) by a stop codon (TGA) at codon 427 (p.Cys427X) 34
amino acids before the end of the 2B domain of K10
(Figure 4). No other pathogenic mutations were detected
within the helix initiation and termination motifs of K1, K10,
K2, or the linker domain (L12) of K10 in the patient’s DNA.
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Both parents were heterozygous carriers of the same
dinucleotide substitution mutation (Figure 3a). This mutation
was not found in 100 normal unrelated alleles (50
individuals) by direct sequence analysis and was unlikely to
be a polymorphism. By mutant allele-specific amplification
(MASA) analysis (Hasegawa et al., 1995; Xu et al., 2003), a
197 bp fragment derived from the mutant allele was amplified
from the patient’s genomic DNA (Figure 3b). The 197 bp
fragment was sequenced and it was confirmed that this
fragment was derived from the targeted region of KRT10.
MASA showed no PCR product band from control DNA
samples (Figure 3b).
K10 protein is absent in the patient’s epidermis
Immunohistochemically, three antibodies recognizing K10
(KL1, RKSE60, and PRB-159P) failed to label the patient’s
epidermis (Figure 2c), whereas on normal control human
skin, all these antibodies labeled suprabasal keratinocytes. An
antibody to K1, K5, K10, and K14 labeled all epidermal layers
of the patient’s skin but in a more or less patchy pattern,
weaker than that obtained on control normal skin. An anti-
K5/6 antibody labeled all epidermal layers, with a maximal
intensity at the level of basal keratinocytes (Figure 2d).
DISCUSSION
Bullous congenital ichthyosiform erythroderma is considered
to be a dominantly inherited disorder caused by K1 or K10
mutations. Generally, in keratin diseases, keratin missense
mutations lead to mutant keratin polypeptides and disturbed
keratin filament network in a dominant-negative manner and
formation of keratin filament clumps within the cytoplasm
(Smith, 2003; Lane and McLean, 2004).
In this study, we report a girl with a recessive form of BCIE
due to a previously unidentified nonsense mutation
p.Cys427X in KRT10. To our knowledge, only one family
with a recessive form of BCIE has been previously reported
(Mu¨ller et al., 2006). In that family, the affected individuals
were homozygous for the nonsense mutation p.Gln434X in
the 2B domain of K10, whereas the unaffected parents were
heterozygous carriers of the mutation (Mu¨ller et al., 2006).
On the basis of the position of the premature stop codon, the
truncated K10 polypeptide lacked 27 amino acids in the 2B
domain in the family (Mu¨ller et al., 2006). In the family
reported here, the nonsense mutation, the second nonsense
mutation reported in a human suprabasal keratin, was
upstream of the previously reported nonsense mutation and
was predicted to cause the loss of 34 C-terminal amino acids
Figure 1. The patient’s clinical features. (a and b) Clinical features at birth. (a) The patient showed generalized erythroderma and blisters. (b) Superficial
erosions were seen on the neck and chest. (c and d) At the age of 3 years, the patient had verrucous, hyperkeratotic plaques, from light to dark brown
in color, and superficial erosions on the chest, abdomen (c) and the back (d). (d, inset) A superficial denuded area in the hyperkeratotic skin
(maserung phenomenon)-like erosion on the back.
Figure 2. Granular degeneration, clumped keratin filaments, and keratin
expression patterns in the patient’s epidermis. (a) Hyperkeratosis and
granular degeneration with large keratohyalin granules were noted in the
uppermost spinous and the granular layers of the patient’s epidermis.
Bar¼50 mm. (b) Electron microscopic examination of the superficial
epidermal keratinocytes revealed a large number of keratin filament clumps
(arrows) only in the uppermost spinous and granular layer cells. Inset:
high-power view of a keratin clump. Bars¼ 2.5 mm (inset, 0.6 mm). (c)
Immunohistochemically, no staining is observed with an anti-K10 antibody,
suggesting absence of K10 in the patient’s epidermis. Bar¼ 50mm. (d) K5/K6
brown labeling is observed in the whole epidermis of the patient’s skin,
with a maximal intensity in the basal cell layer. Bar¼50 mm.
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of the 2B domain including the entire helix termination motif
(Figure 4). In the previously reported family, the truncation
mutation led to nonsense-mediated messenger RNA decay
(NMD) and the existence of a truncated K10 gene product
was excluded (Mu¨ller et al., 2006). NMD is linked to a
splicing-dependent deposition of an exon-junction complex
close to each exon–exon junction. An exon-junction complex
is essential for anchoring the NMD-specific factors upf2 and
upf3 to the targeted mRNA. During the process of ribosomal
translation, exon-junction complexes are displaced from the
open-reading frame and NMD is prevented. In case the
mRNA has a premature termination codon located more than
a certain range upstream of at least one exon-junction
complex, the exon-junction complex downstream of the
premature termination codon is not removed from the
mRNA, triggering NMD (Lejeune and Maquat, 2005; Mu¨ller
et al., 2006). The distance from premature termination sites
to the downstream 30-most exon–exon junction required for
triggering NMD seems to vary depending on the gene.
All nonsense mutations reported in autosomal-dominant
epidermolysis bullosa simplex to date are located less than
92 nucleotides upstream of the 30-most exon–exon junction.
In contrast, in p.Gln434X in K10 and p.Gln396X in K14
reported in families with recessive inheritance, the distance
from the 30-most exon–exon junctions are 476 nucleotides
and 274 nucleotides, respectively. From these data, in keratin
genes, premature termination codons located more than 92
nucleotides upstream to the 30-most exon–exon junction are
expected to be targeted by NMD (Mu¨ller et al., 2006). In this
context, the present nonsense mutation p.Cys427X located
497 nucleotides upstream to the 30-most exon–exon junction
is thought to be targeted by NMD in the present patient, as
was the case of the patients reported by Mu¨ller et al. (2006).
Both in the previously reported family (Mu¨ller et al., 2006)
and the present one with recessive forms of BCIE, the
heterozygous family members were clinically unaffected.
This fact clearly suggests that the K10 peptide derived
from the normal allele was sufficient for normal keratin
network formation in the heterozygous carriers. This implies
that knockout or silencing of the mutant K10 allele might
theoretically be useful as a form of gene therapy in dominant
BCIE caused by K10 mutations.
Interestingly, our patient showed granular degeneration
restricted to the granular layer, leading to superficial
blistering, and mild BCIE phenotype. In the recessive forms
of BCIE, K16 and K17 are compensatively expressed,
especially in the superficial epidermis, and are thought to
form unstable or less stable heterodimers with K1 resulting in
keratin clumps in the superficial epidermis (Mu¨ller et al.,
2006). In our patient, we found immunohistochemical
labeling of suprabasal epidermal layers by antibodies to
K5/6/14, suggesting compensatory expression of one or
more of these keratins by suprabasal keratinocytes.
Additional supportive data on animals were reported. K10
gene knockout and K10 null mice are known to show a very
mild phenotype (Reichelt et al., 2001). In the knockout
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Figure 3. A homozygous dinucleotide substitution mutation c.1281_1282CC4AA in KRT10 was detected in the patient. (a) Direct sequencing of KRT10
exon 6 PCR products revealed that the patient was a homozygote for the dinucleotide substitution mutation c.1281_1282CC4AA, whereas both her parents
were heterozygous for the same mutation. (b) Mutant allele-specific amplification (MASA) analysis. With normal allele-specific primers, no amplification
band was seen in the PCR product from the patient’s DNA samples, suggesting that she had no normal allele. With mutant allele-specific primers, the
amplification band from the mutant alleles was detected as a 197 bp fragment only in the PCR product from the DNA sample from the patient, but not in the PCR
product from control DNA samples, confirming the presence of the mutation c.1281_1282CC4AA in the patient.
Domain structure of K10 and truncation mutations
100 amino acids
   p.Cys427X
(present  family)
     p.Gln434X
(Muller et al., 2006)..
H1 1B1A 2A 2B
Figure 4. The truncation mutation sites of K10 in the recessive form of BCIE.
The nonsense mutation detected in the present family is marked with red
characters. The other, previously reported nonsense mutation in exon 6 lead
to mRNA decay (Mu¨ller et al., 2006). By the present mutation, the
downstream domain (from the dotted line) was not translated, probably
resulting in mRNA decay, because the present mutation was upstream of
the previous mutation in the same exon 6 (Lejeune and Maquat, 2005).
Red areas: helix initiation or termination motif.
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mouse epidermis, the basal keratins K5, K14, and K15 seem
to be stabilized in the suprabasal layers, and it is hypo-
thesized that the lack of K10 is compensated by the residual
basal keratins K5 and K14 in suprabasal epidermal layers in
K10 knockout mouse model (Reichelt et al., 2001; Mu¨ller
et al., 2006). Keratin aggregates were shown to consist of
residual K1 and K14 in the model mouse (Reichelt et al.,
2001). Thus, an intact epidermis showing no fragility or
cytolysis was seen in the K10 knockout mice (Reichelt et al.,
2001; Reichelt and Magin, 2002). In the previously reported
K10 knockout human patients, persistence of K14 expression
in suprabasal layers was also detected, although basal
keratins were not able to compensate completely for the
loss of K10 in human K10 knockout patients (Mu¨ller et al.,
2006). In an pedigree of Norfolk terrier dogs with autosomal-
recessive epidermolytic ichthyosis harboring a canine KRT10
splice-site mutation, homozygotes were reported to show
mild phenotype and heterozygotes were not affected
(Credille et al., 2005). K10 was absent in the homo-
zygous dogs, and pathomechanisms similar to those of
human K10 knockout patients are speculated in these K10
knockout dogs.
MATERIALS AND METHODS
Mutation detection
For mutational analysis, genomic DNA was isolated from peripheral
blood leukocytes of the patient and her parents. DNA was extracted
with phenol–chloroform, precipitated with ethanol, and re-suspended
in TE solution (10mM Tris-HCl, pH 7.4, 1mM EDTA). DNA encoding
the N-terminal region of the 1A domain, which includes the helix
initiation motif, and the C-terminal region of the 2B domain, which
includes the helix termination motif, were amplified for the K1, K10,
and K2 genes (KRT1, KRT10, and KRT2) (GenBank accession nos.
NT029419, NT010755, and NP000414). DNA encoding the linker
domain L12 of K10 was also amplified. Specifically, exon 6, which
encodes the 2B region of K10, was amplified using the specific
oligonucleotide primers: sense, 50-agcgtcaccatactcaactgagc-30 and
anti-sense, 50-tggcatcttcttggggttta-30. PCR products were subjected to
an ABI 310 automated sequencer (Perkin Elmer-ABI, Foster City, CA)
for nucleotide sequencing.
Mutant allele-specific amplification analysis
For the verification of the mutation, using PCR products as a
template, MASA analysis was performed with mutant allele-specific
primers carrying the substitution of two bases at the 30-end (Linard
et al., 2002; Sapio et al., 2006) mutant allele-specific primers:
forward, tcgagctgaaaccgagtgaa; reverse, tggcatcttcttggggttta; normal
allele-specific primers: forward, tcgagctgaaaccgagtgcc; reverse,
tggcatcttcttggggttta. PCR conditions were as follows: 94 1C for
5minutes after (hot-start procedure) and then 94 1C for 1minute,
56 1C for 1minute, 72 1C for 1minute during 35 cycles, followed by
72 1C for 7minutes.
Ultrastructural observation
Skin biopsy samples were fixed in 2% glutaraldehyde solution,
post-fixed in 1% OsO4, dehydrated, and embedded in Epon 812.
The samples were sectioned at 1mm thickness for light microscopy
and thin-sectioned for electron microscopy (70 nm thick). The thin
sections were stained with uranyl acetate and lead citrate, and
examined under a transmission electron microscope.
The medical ethical committee at Hokkaido University Graduate
School of Medicine and Ed. Herriot Hospital approved all studies.
The study was conducted according to the Declaration of Helsinki
Principles. Participants or their legal guardians gave their written
informed consent.
Immunohistochemical staining
Immunohistochemical examination was performed on formalin-
fixed, paraffin-embedded skin sections after deparaffinization and
rehydration, with a Ventana ES automated AEC immunohisto-
chemistry system (Ventana Medical Systems, Tucson, AZ) using the
following antibodies: (a) KL1, mouse mAb recognizing K1 and K10
(Immunotech, Marseille, France); (b) RKSE60, mouse mAb recogni-
zing K10 (Monosan, Uden, The Netherlands); (c) PRB-159P, purified
rabbit polyclonal antibody recognizing K10 (Covance, Berkeley,
CA); (d), mouse mAb recognizing K1, K5, K10, and K14 34bE12
(Dako, Copenhagen, Denmark); and (e) D5/16B4, mouse mAb
recognizing K5 and K6 (Dako).
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